tradingkey.logo

Rapid Micro Biosystems Inc

RPID
3.870USD
+0.190+5.16%
종가 02/06, 16:00ET시세는 15분 지연됩니다
171.48M시가총액
손실P/E TTM

Rapid Micro Biosystems Inc

3.870
+0.190+5.16%

자세한 내용은 Rapid Micro Biosystems Inc 회사

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Rapid Micro Biosystems Inc 정보

종목 코드 RPID
회사 이름Rapid Micro Biosystems Inc
상장일Jul 15, 2021
CEOSpignesi (Robert)
직원 수163
유형Ordinary Share
회계 연도 종료Jul 15
주소25 Hartwell Avenue
도시LEXINGTON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02421
전화19783493200
웹사이트https://www.rapidmicrobio.com/
종목 코드 RPID
상장일Jul 15, 2021
CEOSpignesi (Robert)

Rapid Micro Biosystems Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14300.00%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+14300.00%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+14300.00%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14300.00%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+14300.00%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+14300.00%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Product revenue
4.84M
61.74%
Service revenue
3.00M
38.26%
지역별USD
이름
수익
비율
United States
2.85M
36.43%
Germany
1.58M
20.15%
Switzerland
1.39M
17.67%
All other countries
1.10M
14.09%
Japan
915.00K
11.67%
사업별
지역별
사업별USD
이름
수익
비율
Product revenue
4.84M
61.74%
Service revenue
3.00M
38.26%

주식 보유 통계

마지막 업데이트: Fri, Jan 2
마지막 업데이트: Fri, Jan 2
주주
주주 유형
주주
주주
비율
Bain Capital Life Sciences Investors, LLC
21.18%
Kennedy Lewis Investment Management LLC
12.40%
Longitude Capital Management Co., LLC
10.24%
Endeavour Medtech Growth II LP
5.67%
Ally Bridge Group (HK) Limited
4.64%
기타
45.87%
주주
주주
비율
Bain Capital Life Sciences Investors, LLC
21.18%
Kennedy Lewis Investment Management LLC
12.40%
Longitude Capital Management Co., LLC
10.24%
Endeavour Medtech Growth II LP
5.67%
Ally Bridge Group (HK) Limited
4.64%
기타
45.87%
주주 유형
주주
비율
Investment Advisor
37.25%
Venture Capital
10.30%
Investment Advisor/Hedge Fund
6.65%
Corporation
5.67%
Hedge Fund
4.22%
Individual Investor
3.85%
Private Equity
1.45%
Research Firm
0.11%
기타
30.50%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
59
23.36M
58.78%
-1.87M
2025Q3
56
23.72M
59.74%
-1.53M
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
2023Q3
163
30.20M
81.80%
-11.32M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Bain Capital Life Sciences Investors, LLC
8.43M
21.18%
--
--
Sep 30, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.4%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
3.56M
8.93%
--
--
Apr 07, 2025
Endeavour Medtech Growth II LP
2.26M
5.67%
--
--
Apr 07, 2025
Ally Bridge Group (HK) Limited
1.85M
4.64%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
965.02K
2.42%
+60.66K
+6.71%
Sep 30, 2025
Parkman Healthcare Partners LLC
913.44K
2.29%
--
--
Sep 30, 2025
Schonfeld Strategic Advisors LLC
646.58K
1.62%
-391.09K
-37.69%
Sep 30, 2025
Advent International L.P.
577.78K
1.45%
--
--
Sep 30, 2025
Spignesi (Robert G JR)
498.32K
1.25%
+4.39K
+0.89%
Oct 17, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
비율0.02%
Dimensional US Core Equity 1 ETF
비율0%
Avantis US Small Cap Equity ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI